Wikipedia
Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.
The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.
advertisement
All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Previous article：
HPV cancer vaccine study demonstrates efficacy
Next article： What does generative AI mean for health care? We asked experts
Next article： What does generative AI mean for health care? We asked experts
